Special Issue "Acute and Long-Term Sequelae of Childhood Cancer Therapy"
A special issue of Children (ISSN 2227-9067).
Deadline for manuscript submissions: closed (31 May 2014)
Dr. Paul Nathan
Director, AfterCare Program, Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
Interests: childhood cancer survivorship; health care utilization; anthracycline cardiotoxicity
Dr. Lillian Sung
Staff Physician Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
Interests: infectious complications; supportive care; mucositis; quality of life
Tremendous improvements in the probability of long-term survival in children newly diagnosed with cancer have allowed for an increased focus on minimizing both the acute toxicities and the long-term sequelae (late effects) of cancer therapies. The focus of research in these areas has expanded from efforts to document the risks of acute and late effect, to exploring methods to identify those children at greatest risk, and to prevent or minimize the risks for toxicity. This special issue of Children will serve as a forum for discussion of the latest research in symptom management and detection/prevention of late effects. Both reviews and original research publications will be considered for publication. Examples could include manuscripts that discuss acute toxicities such as infection, mucositis and emesis, or late effects such as cardiac toxicity, neurocognitive deficits and hearing loss.
We look forward to receiving your contributions.
Drs. Paul Nathan
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- late effects
- treatment toxicity
- childhood cancer
- hearing loss
- supportive care
- care plans
- anthracycline cardiotoxicity
- neurocognitive outcomes